CIK 0001603454
- Non-accelerated filer
- Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- 4 Open-market sale Director sold 300 shares at $11.11 ($3,334)
- 4 Open-market buy Chief Executive Officer bought 260,869 shares at $5.75 ($1,499,997)
- 4 Exercise or conversion Director acquired 250 shares (option exercise)
- 4 Open-market buy Director bought 5,000 shares at $9.68 ($48,383)
- 4 Open-market sale Director sold 300 shares at $9.97 ($2,991)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $8.99 ($44,939)
- 4 Open-market sale Director sold 100 shares at $10.02 ($1,002)
- 4 Open-market sale Director sold 350 shares at an average $10.01 ($3,503)
- 4 Open-market sale Director sold 300 shares at $8.95 ($2,685)
- 4 Open-market sale Director sold 300 shares at $9.47 ($2,841)
- 4 Open-market buy Director bought 754 shares at $5.94 ($4,482)
- 4 Open-market sale Director sold 750 shares at $6.24 ($4,683)
- 4 Open-market sale Director sold 250 shares at $5.65 ($1,413)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,273 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 6 of 10 · 187 filings